Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

14 Jan 2021 07:00

RNS Number : 6127L
Xaar PLC
14 January 2021
Β 

Xaar plc

Β 

Trading updateΒ 

Β 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology, today announces a trading update for the year ended 31 December 2020.

Β 

TRADING

Β 

The Board is pleased to announce that, with the on-going successful implementation of the new strategy, trading was in line with its expectations. Revenue for the year was approximately Β£48m and in line with that recorded in FY2019.

Β 

The Printhead business continues to perform well with continued success in winning new customers. The customer-centric approach and focus on markets in which we have a competitive advantage is driving new business wins and seeing customers continue to re-engage. Additionally, our ImagineX platform is being successfully rolled out with a targeted product roadmap and clear growth opportunities ahead.

Β 

Despite the impact by COVID-19, our Product Print Systems business (EPS) has made progress with the strategy of developing a modular approach to products and, following the successful implementation of operational changes, the business is well placedΒ for the future.

Β 

We have made further progress with product development and testing in Xaar 3D, despite continued COVID-19 related delays, and we continue to work closely with Stratasys to optimise the approach to commercialisation of the product range.Β 

Β 

BALANCE SHEET AND LIQUIDITY

Β 

The Group retains a strong balance sheet and cash position. Cash and cash equivalents at 31 December 2020 were Β£20.2m. This was driven by positive operational cash generation in both Printhead and EPS, as well as maintaining a strong focus on cash and disciplined cost controls.

Β 

CURRENT TRADING AND OUTLOOK

Β 

Despite the most recent COVID-19 lockdown, with pro-active management, we have maintained operational performance. Whilst COVID-19 continues to represent a key risk the order book remains strong with a positive pipeline. We continue to rigorously review opportunities available in the market, remaining focused on our strategy, and are on-track to return to profitability and growth.

Β 

Β 

John Mills, Chief Executive Officer, commented:

Β 

"We are very pleased with performance for the year which is a testament to the efforts of the team in extraordinary circumstances. We are one year into delivering our strategy and it is clearly having a positive impact, notably as existing customers continue to engage, and we are winning new business. We remain excited by the future and will remain disciplined in delivering long-term sustainable growth."

Β 

Enquiries:

Β 

Xaar plc

Β 

Ian Tichias, Chief Finance Officer

& Company Secretary

+44 (0) 1223 423 663Β 

John Mills, Chief Executive Officer

Β 

Β 

Β 

Tulchan Communications

James Macey White

Giles Kernick

Tom Blundell

Β 

Β 

Β 

+44 (0) 207 353 4200

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDXLFFFFLFBBV
Date   Source Headline
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company
8th Nov 20194:15 pmRNSPublication - Circular & Notice of General Meeting
1st Nov 201912:50 pmRNSTotal Voting Rights
23rd Oct 20198:30 amRNSHolding(s) in Company
23rd Oct 20198:30 amRNSHolding(s) in Company
11th Oct 20197:00 amRNSCEO Succession
8th Oct 20193:33 pmRNSHolding(s) in Company
8th Oct 20192:46 pmRNSHolding(s) in Company
7th Oct 201912:57 pmRNSGrant of Options
3rd Oct 20191:54 pmRNSHolding(s) in Company
1st Oct 20195:20 pmRNSTotal Voting Rights
1st Oct 20199:10 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSBoard Changes and Succession
26th Sep 20197:00 amRNS2019 Interim Results
12th Sep 20197:00 amRNSProposed investment by Stratasys in Xaar 3D
3rd Sep 20197:00 amRNSTrading update & revised date for interim results
2nd Sep 201910:45 amRNSTotal Voting Rights
1st Aug 201910:39 amRNSTotal Voting Rights
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20199:36 amRNSChange of Auditor
8th Jul 20197:00 amRNSScheduled Trading Statement
4th Jul 20195:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20193:04 pmRNSTotal Voting Rights
5th Jun 20195:05 pmRNSTotal Voting Rights
28th May 201911:41 amRNSHolding(s) in Company
28th May 20199:08 amRNSHolding(s) in Company
21st May 20193:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.